This article contains the histomorphometric evaluation of the effects
of prostaglandin F-2 alpha (PGF(2 alpha)) on cancellous bone from the
lumbar vertebra and cortical bone from the tibial shaft of ovariectomi
zed, osteopenic rats, These effects were then compared with those of p
rostaglandin E(2) (PGE(2)). Three-month-old rats were either ovariecto
mized (ovx) or shamovx. Then, either PGF(2 alpha) or PGE(2) in doses o
f 1 and 3 mg/ kg/day was given subcutaneously for 21 days at 150 days
post ovx, Histomorphometric analysis was performed separately on both
the primary and secondary spongiosae of the fourth lumbar vertebral bo
dies (LVB) and on tibial shafts, The ovx rats exhibited osteopenia in
both primary (-23% to -37%) and secondary (-20%) spongiosae of the LVB
, but not in the tibial shafts at 150 and 171 days post ovx, In the LV
B, PGE(2) in doses of 1 or 3 mg/kg/day for 21 days restored trabecular
bone volume to the levels of sham-ovx controls in the primary spongio
sa, However, in the secondary spongiosa, the treatments only thickened
the trabeculae. The effects of the PGF(2 alpha) treatment were simila
r to those of the PGE(2) in both the primary and the secondary spongio
sae. While both PGF(2 alpha) and PGE(2) treatments stimulated bone for
mation in the LVB as indicated by the increases in labeled perimeter,
tissue and bone area-based bone formation rates, PGE(2) is about 10 ti
mes more potent than PGF(2 alpha) in these effects. The PGE, treatment
also elevated activation frequency in the LVB, while the PGF(2 alpha)
treatment did not, The treatments differed in that PGE(2) at these do
se levels did not alter the eroded surface in the LVB while PGF(2 alph
a) decreased it significantly, Thus, the increase of the ratio of labe
led to eroded perimeter in the LVB in PGF(2 alpha)-treated animals was
much more than that in PGE(2)-treated animals, In the tibial shafts,
PGE(2) in doses of 1 and 3 mg/kg/day produced new marrow trabeculae in
2 of 6 and 3 of 6 of the ovx rats, However, no new trabecula was foun
d in PGF(2 alpha)-treated tibial shafts, Higher doses of PGE(2) also i
ncreased periosteal labeled perimeter, MAR, and BFR/BS, while PGF(2 al
pha) did not produce any significant change in these parameters, Both
PGE(2) and PGF(2 alpha) in doses of 1 and 3 mg/kg/day increased the la
beled perimeter, MAR and BFR/BS and decreased the eroded pe rimeter in
the endocortical surface, We concluded that both PGF(2 alpha) and PGE
(2) in doses of 1 and 3 mg/kg/day for 21 days exhibited anabolic bone
effects, The effects were mostly confined to an increase in trabecular
volume in the primary spongiosa of the LVB and in the endocortical su
rface of tibial shafts, The tissue level mechanism behind this appears
to be that PGE(2) and PGF(2 alpha) can both stimulate osteoblast recr
uitment and activity, Overall, we found PGE(2) to be more potent than
PGF(2 alpha) at the same dose level at the endocortical surface, Furth
ermore, new marrow trabecular bone formed only after PGE(2) treatment,
PGF(2 alpha) differed from PGE(2) by significantly reducing the trabe
cular eroded surface in ovx rats.